Rimsha Shaukat
Hematology & Oncology · Shreveport, LANPI 1992358352
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.3% of the total across 91 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 18.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $830, 3.9 times the $214 reported in 2022. That places this record below the midpoint for hematology & oncology clinicians in LA, where the typical reported total is $4,451.
Across 91 payments — averaging $21.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Daiichi Sankyo Inc.$376
- Genentech USA, Inc.$182
- Merck$153
- Pfizer$143
- AstraZeneca$133
- Novartis$120
- plus $882 from 23 others
What the payments were for
- Food & beverage$1,81691%
- Education$1749%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Daiichi Sankyo Inc. | 15 | $376 |
| Genentech USA, Inc. | 3 | $182 |
| Merck | 9 | $153 |
| Pfizer | 8 | $143 |
| AstraZeneca(2 entities) | 7 | $133 |
| Novartis | 6 | $120 |
| GSK | 6 | $110 |
| AbbVie | 1 | $99 |
| Eisai Inc. | 4 | $70 |
| Johnson & Johnson | 3 | $67 |
| Recordati_rare_diseases_inc. | 3 | $62 |
| E.r. Squibb & Sons, L.L.C. | 4 | $55 |
| Exelixis Inc. | 2 | $48 |
| Regeneron Healthcare Solutions, Inc. | 2 | $35 |
| Puma Biotechnology, Inc. | 2 | $33 |
| Sobi, Inc | 2 | $32 |
| Gilead | 1 | $32 |
| Bristol Myers Squibb | 2 | $30 |
| Stemline Therapeutics Inc. | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Pharmaessentia USA Corporation | 1 | $22 |
| Tempus AI, Inc | 1 | $20 |
| Beone Medicines USA, Inc. | 1 | $19 |
| Secura Bio, Inc. | 1 | $18 |
| Beigene USA, Inc. | 1 | $18 |
| Taiho Oncology, Inc. | 1 | $17 |
| Agios Pharmaceuticals, Inc. | 1 | $16 |
| Bayer | 1 | $16 |
| Emmaus Medical, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TECENTRIQ$148
How this compares
$1,990 in reported general payments places this provider in the 25th percentile of 183 hematology & oncology providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PyrukyndMitapivat Sulfate | 11 | $281,398 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 18 | $376 |
| Morphine Sulfate ErMorphine Sulfate | 12 | $331 |
| Anastrozole | 17 | $306 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Agios Pharmaceuticals, Inc.Pyrukynd | $16 | $281,39811 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 25th percentile of 183 hematology & oncology providers in Louisiana.
Other hematology & oncology in Shreveport
- Prakash PeddiShreveport$405K
- Kevin GallagherShreveport$145K
- Maxwell McDonaldShreveport$123K
- Kirtan KotichaShreveport$45K
- Tharwat GhattasShreveport$25K
- Joyce FeaginShreveport$19K
- Richard MansourShreveport$16K
- Kavitha BeedupalliShreveport$15K
- Steven BoniolShreveport$14K
- Gary BurtonShreveport$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.